Insider Selling: Afya (NASDAQ:AFYA) CEO Sells 19,500 Shares of Stock

Afya Limited (NASDAQ:AFYA) CEO Virgilio Deloy Capobian Gibbon sold 19,500 shares of the stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $14.98, for a total transaction of $292,110.00. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Virgilio Deloy Capobian Gibbon also recently made the following trade(s):

• On Tuesday, March 31st, Virgilio Deloy Capobian Gibbon sold 2,320 shares of Afya stock. The shares were sold at an average price of $14.92, for a total transaction of $34,614.40.
• On Thursday, March 26th, Virgilio Deloy Capobian Gibbon sold 800 shares of Afya stock. The stock was sold at an average price of $15.21, for a total transaction of $12,168.00.
• On Wednesday, March 25th, Virgilio Deloy Capobian Gibbon sold 3,900 shares of Afya stock. The stock was sold at an average price of $15.18, for a total transaction of $59,202.00.

Afya Stock Down 0.2%

Shares of NASDAQ AFYA traded down $0.03 during mid-day trading on Thursday, hitting $14.94. The company had a trading volume of 81,377 shares, compared to its average volume of 116,128. The company has a current ratio of 2.20, a quick ratio of 0.98 and a debt-to-equity ratio of 0.21. The firm has a 50-day simple moving average of $14.45 and a two-hundred day simple moving average of $14.73. The company has a market capitalization of $1.40 billion, a PE ratio of 10.23, a price-to-earnings-growth ratio of 0.66 and a beta of 0.48. Afya Limited has a one year low of $13.00 and a one year high of $19.90.

Afya (NASDAQ:AFYA) last released its earnings results on Wednesday, March 11th. The company reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.05. The business had revenue of $147.08 million for the quarter, compared to analyst estimates of $174.74 million. Afya had a return on equity of 18.77% and a net margin of 20.31%. On average, equities analysts expect that Afya Limited will post 1.52 EPS for the current year.

Afya Dividend Announcement

The business also recently disclosed an annual dividend, which will be paid on Monday, April 6th. Stockholders of record on Wednesday, March 25th will be issued a $0.656 dividend. This represents a dividend yield of 433.0%. The ex-dividend date of this dividend is Wednesday, March 25th. Afya’s dividend payout ratio is presently 44.52%.

Wall Street Analyst Weigh In

AFYA has been the topic of several analyst reports. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Afya in a research report on Wednesday, January 21st. Sanford C. Bernstein upgraded shares of Afya to a “market perform” rating in a research note on Friday, January 16th. Bank of America cut Afya from a “buy” rating to a “neutral” rating and cut their price objective for the company from $22.00 to $17.00 in a research report on Tuesday, February 24th. Zacks Research upgraded Afya from a “strong sell” rating to a “hold” rating in a research note on Monday, March 9th. Finally, UBS Group restated a “neutral” rating and issued a $16.00 price target (down from $18.00) on shares of Afya in a research note on Friday, January 16th. One equities research analyst has rated the stock with a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat, Afya presently has an average rating of “Hold” and an average target price of $17.30.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. Swedbank AB bought a new position in Afya in the 3rd quarter valued at about $1,092,000. SPX Gestao de Recursos Ltda acquired a new stake in Afya during the 3rd quarter worth approximately $2,895,000. Doma Perpetual Capital Management LLC lifted its holdings in Afya by 50.6% during the 3rd quarter. Doma Perpetual Capital Management LLC now owns 891,639 shares of the company’s stock worth $13,910,000 after purchasing an additional 299,419 shares during the last quarter. Dodge & Cox boosted its stake in Afya by 12.8% in the 2nd quarter. Dodge & Cox now owns 35,262 shares of the company’s stock valued at $630,000 after purchasing an additional 4,000 shares during the period. Finally, Quadrature Capital Ltd acquired a new position in Afya in the 2nd quarter valued at $181,000. Institutional investors and hedge funds own 88.02% of the company’s stock.

About Afya

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.